Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Treatment duration of adjuvant immune checkpoint inhibito... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Treatment duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: A prospective, multicentric cohort study
0
Authors
Jia‐Yong Su
21 more
Jia‐Yong Su
•
Baowei Zhao
19 more
•
Jian‐Hong Zhong
Published
December 4, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Liver Cancer
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Hepatology
Show all topics
DOI
10.1159/000542954
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Liver Cancer
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Hepatology
Show all topics
DOI
10.1159/000542954
License
CC-BY-NC
